Peter MacCallum Cancer Centre


Forschungseinrichtung

Standort der Organisation:
Melbourne, Australien


Publikationen in Kooperation mit FAU-Wissenschaftern


Go to first page Go to previous page 1 von 2 Go to next page Go to last page
Heinzerling, L., Ascierto, P.A., Dummer, R., Gogas, H., Grob, J.-J., Lebbe, C.,... Hauschild, A. (2019). Adverse events 2.0-Let us get SERIOs New reporting for adverse event outcomes needed in the era of immunooncology. European journal of cancer, 112, 29-31. https://dx.doi.org/10.1016/j.ejca.2019.01.015
Buckley, M.A., Woods, N.T., Tyrer, J.P., Mendoza-Fandino, G., Lawrenson, K., Hazelett, D.J.,... Freedman, M.L. (2019). Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-17-3864
Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X.-O., Cai, Q.,... Long, J. (2019). Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Cancer Research, 79(3). https://dx.doi.org/10.1158/0008-5472.CAN-18-2726
Earp, M., Tyrer, J.P., Winham, S.J., Lin, H.-Y., Chornokur, G., Dennis, J.,... Phelan, C.M. (2018). Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. PLoS ONE, 13(7). https://dx.doi.org/10.1371/journal.pone.0197561
Goode, E.L., Block, M.S., Kalli, K.R., Vierkant, R.A., Chen, W., Fogarty, Z.C.,... Ramus, S.J. (2017). Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. JAMA Oncology, 3(12). https://dx.doi.org/10.1001/jamaoncol.2017.3290
Kar, S.P., Adler, E., Tyrer, J., Hazelett, D., Anton-Culver, H., Bandera, E.V.,... Lawrenson, K. (2017). Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer, 116(4), 524-535. https://dx.doi.org/10.1038/bjc.2016.426
Loibl, S., De La Pena, L., Nekljudova, V., Zardavas, D., Michiels, S., Denkert, C.,... Loi, S. (2017). Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE). European journal of cancer, 85, 133-145. https://dx.doi.org/10.1016/j.ejca.2017.08.020
Dixon, S.C., Nagle, C.M., Thrift, A.P., Pharoah, P.D.P., Pearce, C.L., Zheng, W.,... Webb, P.M. (2016). Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology, 45(3), 884-95. https://dx.doi.org/10.1093/ije/dyw158
Cuellar-Partida, G., Lu, Y., Dixon, S.C., Fasching, P.A., Hein, A., Burghaus, S.,... Macgregor, S. (2016). Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human genetics, 135(7), 741-56. https://dx.doi.org/10.1007/s00439-016-1663-9
Hampras, S.S., Sucheston-Campbell, L.E., Cannioto, R., Chang-Claude, J., Modugno, F., Doerk, T.,... Moysich, K.B. (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. https://dx.doi.org/10.18632/oncotarget.10215
Ong, J.-S., Cuellar-Partida, G., Lu, Y., Fasching, P.A., Hein, A., Burghaus, S.,... Macgregor, S. (2016). Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology, 45(5), 1619-1630. https://dx.doi.org/10.1093/ije/dyw207
Permuth, J.B., Reid, B., Earp, M., Chen, Y.A., Monteiro, A.N.A., Chen, Z.,... Sellers, T.A. (2016). Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget, 7(45), 72381-72394. https://dx.doi.org/10.18632/oncotarget.10546
Easton, D.F., Lesueur, F., Decker, B., Michailidou, K., Li, J., Allen, J.,... Chenevix-Trench, G. (2016). No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of Medical Genetics, 53(5), 298-309. https://dx.doi.org/10.1136/jmedgenet-2015-103529
Denkert, C., Wienert, S., Poterie, A., Loibl, S., Budczies, J., Badve, S.,... Salgado, R. (2016). Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group. Modern Pathology, 29(10), 1155-64. https://dx.doi.org/10.1038/modpathol.2016.109
Lawrenson, K., Li, Q., Kar, S., Seo, J.-H., Tyrer, J., Spindler, T.J.,... Defazio, A. (2015). Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications, 6, 8234. https://dx.doi.org/10.1038/ncomms9234
Chornokur, G., Lin, H.-Y., Tyrer, J.P., Lawrenson, K., Dennis, J., Amankwah, E.K.,... Phelan, C.M. (2015). Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PLoS ONE, 10(6), e0128106. https://dx.doi.org/10.1371/journal.pone.0128106
Lawrenson, K., Iversen, E.S., Tyrer, J., Weber, R.P., Concannon, P., Hazelett, D.J.,... Schildkraut, J.M. (2015). Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. Carcinogenesis, 36(11), 1341-53. https://dx.doi.org/10.1093/carcin/bgv138
Amankwah, E.K., Lin, H.-Y., Tyrer, J.P., Lawrenson, K., Dennis, J., Chornokur, G.,... Phelan, C.M. (2015). Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology, 39(8), 689-97. https://dx.doi.org/10.1002/gepi.21921
Johnatty, S.E., Tyrer, J.P., Kar, S., Beesley, J., Lu, Y., Gao, B.,... Chenevix-Trench, G. (2015). Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research, 21(23), 5264-76. https://dx.doi.org/10.1158/1078-0432.CCR-15-0632
Kar, S.P., Tyrer, J.P., Li, Q., Lawrenson, K., Aben, K.K.H., Anton-Culver, H.,... Pharoah, P.D.P. (2015). Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk. Cancer Epidemiology Biomarkers & Prevention, 24(10), 1574-84. https://dx.doi.org/10.1158/1055-9965.EPI-14-1270

Zuletzt aktualisiert 2016-10-05 um 08:26